Search Results for “acquisition” – Page 36 – media

Novo Nordisk to reduce US list prices of insulin products

Novo Nordisk will reduce the list price of four legacy insulin brands, including NovoLog and NovoLog Mix 70/30, by 75%. Novo Nordisk has announced plans to reduce the US wholesale acquisition cost (WAC), also known as the list price, of several pre-filled insulin pens and vials by up to 75% for people living with type 1 and type 2 diabetes. Set to come into effect from 1 January 2024, these changes will be applicable for products including pre-filled pens and vials of basal (long-acting), bolus (short-acting) and pre-mix insulins, Levemir, Novolin, NovoLog and NovoLog Mix 70/30 in specific. Novo Nordisk Market Access & Public Affairs senior vice-president Steve Albers said: “We have been working to develop a sustainable path forward that balances patient affordability, market dynamics, and evolving policy changes. “Novo Nordisk remains committed to ensuring patients living with diabetes can afford our insulins, a responsibility we take seriously.” The company will reduce the ...
- Source: drugdu
- 127
- March 16, 2023
10 Triumphant Drug Launches Of The Decade

The view from 2020: Scrip looks back at the most successful commercial launches of the decade.
- Source: https://scrip.pharmaintelligence.informa.com/SC141426/10-Triumphant-Drug-Launches-Of-The-Decade
- 2,648
- August 26, 2021
Ddu College Market Views
Gilead’s Trodelvy scores accelerated approval in advanced bladder cancer

Gilead’s antibody drug conjugate (ADC) Trodelvy has received an accelerated approval from the US Food and Drug Administration (FDA) for the treatment of locally advanced or metastatic urothelial cancer (UC), the most common form of bladder cancer. The approval covers the use of Trodelvy (sacituzumab govitecan-hziy) in patients with advanced UC who have previously received a platinum-containing chemotherapy and either a PD-1 or PD-L1 inhibitor. Trodelvy was approved on the basis of results from Gilead’s Phase II TROPHY study, which evaluated the drug as monotherapy or as a combination therapy in patients with metastatic UC after progression on a platinum-based chemotherapy and PD-1/L1 inhibitor. In 112 patients who were evaluable for efficacy, 27.7% of those who were treated with Trodelvy responded to treatment, with 5.4% experiencing a complete response and 22.3% experiencing a partial response. The study also found a median duration of response of 7.2 months for those treated ...
- Source: drugdu
- 179
- April 15, 2021
bladder cancer
Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billion

By Ludwig Burger FRANKFURT (Reuters) – Bayer <BAYGn.DE> agreed to acquire unlisted U.S. biotech firm Asklepios BioPharmaceutical Inc for as much as $4 billion in a bet on gene therapy with the help of modified viruses. Germany’s Bayer will pay $2 billion upfront and up to an additional $2 billion in milestone payments contingent on development achievements, it said on Monday. The North Carolina-based takeover target, also known as AskBio, is trying to use the harmless adeno-associated virus as a delivery device to bring genetic repair kits against a range of diseases into the body.Drugs and farming pesticides maker Bayer needs to upgrade its drug development pipeline amid a weaker outlook for agricultural sales and as it seeks to finalise an $11 billion settlement over claims its Roundup weedkiller causes cancer. Among AskBio’s most advanced projects are early tests on volunteers of prospective treatments against Pompe disease – a ...
- Source: drugdu
- 283
- November 2, 2020
Gene therapy
IACS – An Advanced Cell Sorter

The technique of cell sorting can be used to study the cell structures and chromosome patterns. In the medical field cell sorting is used in cancer studies. For the past 50 years, cell sorting by flow cytometry based on phenotypic profiles has been widely used.
- Source: drugdu
- 773
- August 29, 2018
cell medtech Researches
Vitals Consumer Services Division Becomes Second Possession of WebMD in Two Months

WebMD, an Internet Brands company, announced its purchase of Vitals Consumer Services Division from Mdx Medical in a period of two months since its earlier acquisition.
- Source: MobiHealthNews
- 636
- August 6, 2018
Company Insight digital health
Invention of Cortisol Detecting Wearable to Measure Stress

The research team from Stanford University have invented a novel wearable that could measure the level of a patient’s cortisol from their sweat. Cortisol is a hormone linked to stress, which takes several days to test. This scientific discovery was recently published in Science Advances.
- Source: MobiHealthNews
- 680
- July 25, 2018
digital health Researches wearables
PharmaAsia Recap

Recent news regarding pharma companies in Asia
- Source: FiercePharma
- 733
- July 3, 2018
Asia Market Views pharmaceutical company
Good Samaritan a Senior Healthcare Provider Acquired by Sanford Health

Sanford Health, a healthcare delivery system acquired the Evangelical Lutheran Good Samaritan Society, a senior healthcare services provider for an undisclosed amount. Both South Dakota based healthcare providers announced the merge to form a $6 billion company with 47,000 employees nationwide.
- Source: Health Leaders Media
- 654
- June 29, 2018
acquisition Company Insight healthcare
Cotiviti Holdings Acquired by Verscend Technologies for $4.9 Billion

The new business with unique data-driven capabilities will work as a private healthcare IT company with a big impact in the health sector by reducing waste and improving quality outcomes and affordability as well as offering opportunities to create substantial value for clients.
- Source: Healthcare Global
- 755
- June 25, 2018
Company Insight health IT

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.